Patient and blood samples

WD Wanwisa Dejnirattisai
DZ Daming Zhou
HG Helen M. Ginn
HD Helen M.E. Duyvesteyn
PS Piyada Supasa
JC James Brett Case
YZ Yuguang Zhao
TW Thomas S. Walter
AM Alexander J. Mentzer
CL Chang Liu
BW Beibei Wang
GP Guido C. Paesen
JS Jose Slon-Campos
CL César López-Camacho
NK Natasha M. Kafai
AB Adam L. Bailey
RC Rita E. Chen
BY Baoling Ying
CT Craig Thompson
JB Jai Bolton
AF Alex Fyfe
SG Sunetra Gupta
TT Tiong Kit Tan
JG Javier Gilbert-Jaramillo
WJ William James
MK Michael Knight
MC Miles W. Carroll
DS Donal Skelly
CD Christina Dold
YP Yanchun Peng
RL Robert Levin
TD Tao Dong
AP Andrew J. Pollard
JK Julian C. Knight
PK Paul Klenerman
NT Nigel Temperton
DH David R. Hall
MW Mark A. Williams
NP Neil G. Paterson
FB Felicity K.R. Bertram
CS C. Alistair Siebert
DC Daniel K. Clare
AH Andrew Howe
JR Julika Radecke
YS Yun Song
AT Alain R. Townsend
KH Kuan-Ying A. Huang
EF Elizabeth E. Fry
JM Juthathip Mongkolsapaya
MD Michael S. Diamond
request Request a Protocol
ask Ask a question
Favorite

Patients were recruited from the John Radcliffe Hospital in Oxford, UK, between March and May 2020 by identification of patients hospitalised during the SARS-CoV-2 pandemic and recruited into the Sepsis Immunomics project [Oxford REC C, reference:19/SC/0296] ISARIC/WHO Clinical Characterization Protocol for Severe Emerging Infections [Oxford REC C, reference 13/SC/0149]. Time between onset of symptoms and sampling were known for all patients and if labeled as convalescent patients were sampled at least 28 days from the start of their symptoms. Written informed consent was obtained from all patients. All patients were confirmed to have tested positive for SARS-CoV-2 using the reverse transcriptase polymerase chain reaction (RT-PCR) from an upper respiratory tract (nose/throat) swab tested in accredited laboratories. The degree of severity was identified as a mild, severe or critical infection according to recommendations from the World Health Organization. Severe infection was defined for COVID-19 confirmed patients with one of the following conditions: respiratory distress with RR > 30/min; blood oxygen saturation < 93%; arterial oxygen partial pressure (PaO2) / fraction of inspired O2 (FiO2) < 300 mmHg; and critical infection was defined as respiratory failure requiring mechanical ventilation or shock; or other organ failures requiring admission to ICU. Comparator samples from healthcare workers or epidemiologically detected early clusters with confirmed SARS-CoV-2 infection who all had mild non-hospitalised disease were collected under the Gastro-intestinal illness in Oxford: COVID sub study [Sheffield REC, reference: 16/YH/0247].

Blood samples were collected and separated into plasma by centrifugation at 500 g for 10 mins. Plasma was removed from the uppermost layer and stored at −80°C. The PBMC layer was then gently suspended in the remaining plasma and RPMI media, and then isolated by Ficoll-Hypaque gradient centrifugation. All PBMC samples were stored in liquid nitrogen until use.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

0/150

tip Tips for asking effective questions

+ Description

Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.

post Post a Question
0 Q&A